A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancer

International Journal of Radiation Oncology Biology Physics

Volumn 62, Issue 5, 2005, Pages 1332-1338

  Patel, Bhaumik ^a,c   Forman, Jeffrey ^b,c   Fontana, Joseph ^a,d   Frazier, Arthur ^b,c   Pontes, Edson ^a,c   Vaishampayan, Ulka ^a,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c KARMANOS CANCER INSTITUTE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Capecitabine; Elderly; Radiation therapy; Radiosensitization; Urothelial cancer

Indexed keywords

DEHYDRATION; DISEASES; MEDICINE; PATIENT TREATMENT; RADIATION; TOXICITY;

CAPECITABINE; CONCURRENT RADIATION THERAPY; UROTHELIAL CANCER; UROTHELIAL CARCINOMA;

TUMORS;

CAPECITABINE;

ADULT; AGED; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CYSTECTOMY; DEHYDRATION; DIARRHEA; DRUG TOLERABILITY; ELDERLY CARE; FATIGUE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MALE; MEDICAL RECORD; PELVIS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIOSENSITIZATION; REVIEW; UROGENITAL TRACT CANCER;

EID: 22144452832     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.01.004     Document Type: Article

References (28)

1. A. Jemal, R.C. Tiwari, T. Murray Cancer statistics, 2004 CA Cancer J Clin 54 2004 8 29
2. National Cancer Institute. SEER cancer statistics review 1973-1999. Available at: http://seer.cancer.gov/csr/1973_1999/bladder.pdf. Accessed on September 24, 2004.
3. N.E. Fleshner, H.W. Herr, A.K. Stewart The American College of Surgeons Commission on Cancer and the American Cancer Society The National Cancer Data Base report on bladder carcinoma Cancer 78 1996 1505 1513
4. H. Waehre, S. Ous, B. Klevmark A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer Cancer 72 1993 3044 3051
5. F. Pagano, P. Bassi, T.P. Galetti Results of contemporary radical cystectomy for invasive bladder cancer A clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification J Urol 145 1991 45 50
6. C.M. Coppin, M.K. Gospodarowicz, K. James The National Cancer Institute of Canada Clinical Trials Group Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation J Clin Oncol 14 1996 2901 2907
7. K.J. Russell, M.A. Boileau, C. Higano Combined 5-fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder Int J Radiat Oncol Biol Phys 19 1990 693 699
8. M. Rotman, H. Aziz, M. Porrazzo Treatment of advanced transitional cell carcinoma of the bladder with irradiation and concomitant 5-fluorouracil infusion Int J Radiat Oncol Biol Phys 18 1990 1131 1137
9. M. Verso, G. Agnelli Venous thromboembolism associated with long-term use of central venous catheters in cancer patients J Clin Oncol 21 2003 3665 3675
10. J. Arima, Y. Imazono, Y. Takebayashi Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder Cancer 88 2000 1131 1138
11. N. Sawada, T. Ishikawa, F. Sekiguchi X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts Clin Cancer Res 5 1999 2948 2953
12. U.N. Vaishampayan, E. Ben-Josef, P.A. Philip A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies Int J Radiat Oncol Biol Phys 53 2002 675 679
13. F.L. Greene, D.L. Page, I.D. Fleming AJCC cancer staging handbook 6th ed. 2001 Springer Publishers New York
14. National Cancer Institute. Common toxicity criteria 3.0. Available at: http://ctep.cancer.gov/forms/CTCAEv3.pdf. Accessed on September 24, 2004.
15. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 998;47:207-214.
16. A. Moghaddam, H.T. Zhang, T.P. Fan Thymidine phosphorylase is angiogenic and promotes tumor growth Proc Natl Acad Sci U S A 92 1995 998 1002
17. T. Iizumi, K. Hariu, M. Sato Thymidine phosphorylase and dihydropyrimidine dehydrogenase in bladder cancer Urol Int 68 2002 122 125
18. T. Ishikawa, F. Sekiguchi, Y. Fukase Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts Cancer Res 58 1998 685 690
19. J. Dunst, T. Reese, T. Sutter Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer J Clin Oncol 20 2002 3983 3991
20. J. Souglakos, N. Androulakis, D. Mavroudis Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer Int J Radiat Oncol Biol Phys 56 2003 1284 1287
21. R.C. Nichols Jr, M.G. Sweetser, S.K. Mahmood Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder A well-tolerated combination Int J Cancer 90 2000 281 286
22. R.A. Cowan, V.K. Sangar, C.A. McBain A phase I trial of chemoradiation with gemcitabine for muscle invasive bladder carcinoma [abstract] Proc Am Soc Clin Oncol 22 2003 427
23. O. Caffo, G. Fellin, U. Graffer Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer Int J Radiat Oncol Biol Phys 57 2003 1310 1316
24. C. Twelves, M. Boyer, M. Findlay Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma Eur J Cancer 37 2001 597 604
25. W. Tester, R. Caplan, J. Heaney Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer Results of Radiation Therapy Oncology Group phase II trial 8802 J Clin Oncol 14 1996 119 126
26. W. Tester, A. Porter, S. Asbell Combined modality program with possible organ preservation for invasive bladder carcinoma Results of RTOG protocol 85-12 Int J Radiat Oncol Biol Phys 25 1993 783 790
27. R. Sauer, S. Birkenhake, R. Kuhn Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer Int J Radiat Oncol Biol Phys 40 1998 121 127
28. W.U. Shipley, D.S. Kaufman, E. Zehr Selective bladder preservation by combined modality protocol treatment Long-term outcomes of 190 patients with invasive bladder cancer Urology 60 2002 62 68